EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives

Ntokozo Dambuza, Peter Smith, Alicia Evans, Dale Taylor, Kelly Chibale, Lubbe Wiesner

Malaria Research and Treatment · 29.03.2015 · 2015 · 1-5

DOI: 10.1155/2015/405962 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Malaria Research and Treatment, erschienen am 29.03.2015. Verfasst von Ntokozo Dambuza und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 10 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malaria caused by Plasmodium falciparum is responsible for approximately 80% of the incidence and 90% of deaths which occur in the World Health Organization (WHO) African region, with children and pregnant women having the highest incidence. P. falciparum has developed resistance, and therefore new effective candidate antimalarial drugs need to be developed. Previous studies identified 3,5-diaryl-2-aminopyridines as potential antimalarial drug candidates; therefore, derivatives of these compounds were synthesized in order to improve their desired properties and pharmacokinetic (PK) properties of the derivatives were investigated in a mouse model which was dosed orally and intravenously. Collected blood samples were analyzed using liquid chromatography coupled to mass spectrometer (LC-MS/MS). The mean peak plasma level of 1.9 μ M was obtained at 1 hour for compound 1 and 3.3 μ M at 0.5 hours for compound 2. A decline in concentration was observed with a half-life of 2.53 and 0.87 hours for compound 1 in mice dosed orally and intravenously, respectively. For compound 2 a half-life of 2.96 and 0.68 hours was recorded. The bioavailability was 69% and 59.7% for compound 1 and compound 2, respectively.

Autor:innen und Institutionen

  • Division of Clinical Pharmacology, Department of Medicine, University of Cape Town, Observatory, Cape Town 7925, South Africa.
  • Department of Chemistry, University of Cape Town, Rondebosch, Cape Town 7700, South Africa.

Zitieren

APA

Dambuza, N., Smith, P., Evans, A., Taylor, D., Chibale, K., & Wiesner, L. (2015). A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives. Malaria Research and Treatment, 2015, 1-5. https://doi.org/10.1155/2015/405962

Vancouver

Dambuza N, Smith P, Evans A, Taylor D, Chibale K, Wiesner L. A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives. Malaria Research and Treatment. 2015;2015:1-5. doi:10.1155/2015/405962

BibTeX
@article{Dambuza2015,
  author = {Dambuza, Ntokozo and Smith, Peter and Evans, Alicia and Taylor, Dale and Chibale, Kelly and Wiesner, Lubbe},
  title = {A Pharmacokinetic Study of Antimalarial 3,5-Diaryl-2-aminopyridine Derivatives},
  journal = {Malaria Research and Treatment},
  year = {2015},
  volume = {2015},
  pages = {1--5},
  doi = {10.1155/2015/405962}
}
Kostenlos starten →